- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT07657481
Comparison of the Effects of Two Different Home Exercise Programs on Femoral Cartilage Thickness and Clinical Parameters in Individuals With Knee Osteoarthritis: A Randomized Controlled Trial
Knee osteoarthritis (OA) is one of the most common joint disorders worldwide and is a leading cause of pain, limited mobility, and functional disability, particularly in the elderly population (1). According to 2020 data, approximately 654 million individuals aged 40 years and older are affected by knee OA worldwide, with a global prevalence of 22.9% in this age group (2). In our country as well, OA is reported as the second most common rheumatologic disease. The disease not only negatively affects individuals' quality of life but also creates a significant socioeconomic burden through work loss, hospital admissions, and the need for surgical interventions (3).
The pathogenesis of knee OA is a complex process involving articular cartilage degeneration, subchondral bone sclerosis, synovial tissue proliferation, and osteophyte formation. Once cartilage damage begins, its capacity for spontaneous healing is extremely limited; therefore, early interventions aimed at slowing or halting disease progression are of critical importance (4,5). In this context, non-pharmacological interventions, particularly exercise programs that may contribute to maintaining cartilage integrity, are strongly recommended as first-line treatment options in current clinical guidelines (6-8).
The beneficial effects of exercise therapy on pain and function in patients with knee OA are well documented. However, the structural effects of exercise on femoral cartilage thickness have been relatively less investigated. Tuna et al. evaluated femoral cartilage thickness using ultrasonography in 40 patients with knee OA following a 12-week quadriceps strengthening program and reported statistically significant increases in cartilage thickness in the medial condyle, lateral condyle, and intercondylar region at 3 months (9). This pioneering study suggests that muscle strengthening programs may have not only symptomatic but also structural benefits. Similarly, Bozan et al. reported a strong positive correlation between quadriceps muscle thickness (rectus femoris + vastus intermedius) and femoral cartilage thickness, supporting the idea that muscle loss parallels cartilage degeneration (10). However, these studies focused exclusively on the quadriceps muscle, and the effects of hip musculature on femoral cartilage thickness have not been investigated. Recent biomechanical studies indicate that hip abductor and adductor muscles play a critical role in knee joint loading patterns.
Hip abductor muscles provide pelvic stability during gait and directly influence knee adduction moments. Weakness of the gluteus medius leads to contralateral pelvic drop, increasing medial compartment loading on the ipsilateral knee and accelerating medial tibiofemoral cartilage wear (11-14). Indeed, Segal et al., using data from the Multicenter Osteoarthritis Study (MOST), demonstrated via MRI that greater hip abductor strength significantly reduces the risk of progression of medial patellofemoral and lateral tibiofemoral cartilage damage (15). On the other hand, hip adductor muscles are also thought to contribute to knee adduction moments by eccentrically controlling femoral varus motion; however, this relationship has been studied far less compared to quadriceps and abductors (13,16-18).
Systematic reviews and meta-analyses have shown that individuals with knee OA have up to 24% lower isometric hip abductor strength compared to healthy controls (13,14,19). Randomized controlled trials investigating combined hip and quadriceps strengthening programs have reported significant improvements in pain and function. However, none of these studies have used femoral cartilage thickness measured by ultrasonography as a primary outcome.
A review of the current literature reveals that although studies exist examining the effects of quadriceps strengthening on femoral cartilage thickness, no randomized controlled trial has compared hip abductor and adductor strengthening exercises with a quadriceps strengthening program, using ultrasonographic femoral cartilage thickness as the primary outcome measure. This study aims to address this gap. All interventions will be applied as non-invasive home exercise programs, and all measurements will be performed using ultrasonography. Baseline, 1-month, and 3-month assessments will also allow evaluation of the temporal effects of exercise on cartilage structure. The findings are expected to provide scientific evidence regarding the structural protective effects of hip exercises in knee OA rehabilitation and serve as pilot data for future large-scale multicenter studies.
The aim of this study is to compare patients with knee OA receiving quadriceps strengthening exercises alone with those receiving additional hip abductor/adductor strengthening exercises in terms of changes in femoral cartilage thickness, and to evaluate whether there is a correlation between femoral cartilage thickness and the thickness of the rectus femoris, gluteus medius,
Tutkimuksen yleiskatsaus
Tila
Ehdot
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Merve Arbay Celtek
- Puhelinnumero: • +905343371877
- Sähköposti: arbaymerve@gmail.com
Opiskelupaikat
-
-
-
Kütahya, Turkki (Türkiye)
- Kütahya Physical Therapy and Rehabilitation Hospital
-
Ottaa yhteyttä:
- selma karaçam bayındır
- Puhelinnumero: 0 (274) 260 00 43
- Sähköposti: etik.gir.olmayan@ksbu.edu.tr
-
Alatutkija:
- Hasan Celtek
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Aikuinen
- Vanhempi Aikuinen
Hyväksyy terveitä vapaaehtoisia
Kuvaus
Inclusion Criteria:
- Age ≥18 years
- Diagnosis of knee osteoarthritis according to ACR criteria, Kellgren-Lawrence grade 2-3
- Knee pain for at least 3 months
- Having the physical capacity to perform a home exercise program
- Willingness to provide written informed consent
Exclusion Criteria:
- History of knee, hip, or spine surgery
- Active inflammatory arthritis (e.g., rheumatoid arthritis, gout, psoriatic arthritis)
- Intra-articular injection within the last 3 months
- Neurological or neuromuscular disorders
- Body mass index (BMI) > 40 kg/m²
- Pregnancy
- Cardiovascular or orthopedic contraindications preventing participation in a regular exercise program
- Cognitive impairment
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Quadriceps Plus Hip Strengthening Group
For 3 months, 3 days per week, participants will perform quadriceps strengthening exercises combined with hip abductor and adductor strengthening exercises. In addition to all exercises included in the Quadriceps Strengthening Group, participants will perform: Hip abduction (side-lying position with ankle weights) Clamshell exercise (for gluteus medius activation) Hip adduction (supine position with isometric contraction using a pillow) Side-lying hip abduction with a resistance band |
quadriceps strengthening exercises combined with hip abductor and adductor strengthening exercises
|
|
Active Comparator: Quadriceps Strengthening Group
For 3 months, 3 days per week, participants will perform a quadriceps strengthening exercise program only. The program will include: Knee extension (in a seated position, with and without resistance) Terminal knee extension Straight leg raise Mini squat (0-30° knee flexion) |
quadriceps strengthening exercise program
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Medial femoral condyle cartilage thickness (mm)
Aikaikkuna: Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
All ultrasonographic measurements will be performed using a Clarius L7 HD3 linear high-frequency transducer (7.5-12 MHz) with the knee positioned in 90° flexion in a standardized manner.
Three measurements will be obtained at each anatomical location, and the mean value will be recorded for analysis.
|
Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Lateral femoral condyle cartilage thickness (mm)
Aikaikkuna: Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
All ultrasonographic measurements will be performed using a Clarius L7 HD3 linear high-frequency transducer (7.5-12 MHz) with the knee positioned in 90° flexion in a standardized manner.
Three measurements will be obtained at each anatomical location, and the mean value will be recorded for analysis.
|
Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
|
Intercondylar area cartilage thickness (mm)
Aikaikkuna: Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
All ultrasonographic measurements will be performed using a Clarius L7 HD3 linear high-frequency transducer (7.5-12 MHz) with the knee positioned in 90° flexion in a standardized manner.
Three measurements will be obtained at each anatomical location, and the mean value will be recorded for analysis.
|
Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
|
Ultrasound Femoral Cartilage Degeneration Grade
Aikaikkuna: Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
Evaluation will be performed with the symptomatic knee positioned in maximum flexion. Cartilage degeneration will be classified as follows: Grade 1: Blurred margins or partial loss of sharpness without thickness change Grade 2: Blurred margin space with partial loss of sharpness without thickness change Grade 3: Blurred margins with loss of clarity Grade 4: Poorly defined margins with a completely opaque band Grade 5: Evident thickness alteration Grade 6: Cartilage band cannot be visualized |
Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
|
Synovial Hypertrophy Grade
Aikaikkuna: Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
Ultrasound assessment will be performed in accordance with the EULAR and Outcome Measures in Rheumatology Clinical Trials (OMERACT) guidelines using both longitudinal and axial views. For evaluation of synovial hypertrophy, the suprapatellar, medial parapatellar, and lateral parapatellar recesses will be scanned with the knee positioned in 30° flexion. Synovial hypertrophy will be graded as follows: Grade 0: No synovial thickening Grade 1: Mild synovial thickening Grade 2: Moderate synovial thickening Grade 3: Severe synovial thickening |
Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
|
Rectus femoris muscle thickness (cm)
Aikaikkuna: Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
Rectus femoris muscle thickness will be measured with the participant in the supine position and with the hip and knee in extension.
The ultrasound transducer will be placed axially over the muscle.
Measurements will be obtained at the junction between the lower one-third and upper two-thirds of the distance from the anterior superior iliac spine (ASIS) to the superior pole of the patella, which will serve as the anatomical reference point.
|
Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
|
Gluteus medius (GMed) muscle thickness (cm)
Aikaikkuna: Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
Participants will be positioned in side-lying with the left leg uppermost.
The left hip region will be exposed, and a towel will be placed under the ankle to maintain a neutral alignment of the hip, knee, and ankle joints.
To assess the gluteus medius muscle, the ultrasound transducer will be placed longitudinally on the lateral aspect of the hip, just superior to the greater trochanter, at the anterior one-quarter of the line connecting the anterior superior iliac spine (ASIS) and posterior superior iliac spine (PSIS).
|
Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
|
Adductor longus muscle thickness (cm)
Aikaikkuna: Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
Participants will be positioned in the supine position, with the thigh in abduction and external rotation and the knee flexed to 20-30°.
The knee will be supported with a rolled towel.
Measurements will be obtained at the junction between the upper one-third and lower two-thirds of the distance from the pubic symphysis to the medial femoral epicondyle, which will serve as the anatomical reference point.
|
Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
|
Visual Analog Scale (VAS)
Aikaikkuna: Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
The Visual Analog Scale is used to assess pain intensity.
Participants will be asked to indicate the severity of their knee pain on a scale ranging from 0 (no pain) to 10 (worst imaginable pain) by selecting the point that best represents their pain level.
|
Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
|
WOMAC Osteoarthritis Index
Aikaikkuna: Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
The WOMAC Osteoarthritis Index consists of 24 items rated on a 5-point Likert scale.
It includes three subscales: pain, stiffness, and physical function.
The pain subscale contains 5 items and is scored from 0 to 20.
The stiffness subscale includes 2 items and is scored from 0 to 8. The physical function subscale consists of 17 items and is scored from 0 to 68.
Higher scores indicate greater pain, increased stiffness, and poorer functional status.
The Turkish validity and reliability study of the WOMAC scale was conducted by Tüzün et al.
|
Participants receiving treatment will be evaluated at baseline (T0), at Month 1 (T1), and at Month 3 (T2).
|
Yhteistyökumppanit ja tutkijat
Sponsori
Julkaisuja ja hyödyllisiä linkkejä
Yleiset julkaisut
- Whittaker JL, Emery CA. Sonographic measures of the gluteus medius, gluteus minimus, and vastus medialis muscles. J Orthop Sports Phys Ther. 2014 Aug;44(8):627-32. doi: 10.2519/jospt.2014.5315. Epub 2014 Jul 16.
- Tuzun EH, Eker L, Aytar A, Daskapan A, Bayramoglu M. Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthritis Cartilage. 2005 Jan;13(1):28-33. doi: 10.1016/j.joca.2004.10.010.
- Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020 Nov 26;29-30:100587. doi: 10.1016/j.eclinm.2020.100587. eCollection 2020 Dec.
- Tillquist M, Kutsogiannis DJ, Wischmeyer PE, Kummerlen C, Leung R, Stollery D, Karvellas CJ, Preiser JC, Bird N, Kozar R, Heyland DK. Bedside ultrasound is a practical and reliable measurement tool for assessing quadriceps muscle layer thickness. JPEN J Parenter Enteral Nutr. 2014 Sep;38(7):886-90. doi: 10.1177/0148607113501327. Epub 2013 Aug 26.
- Powers CM. The influence of abnormal hip mechanics on knee injury: a biomechanical perspective. J Orthop Sports Phys Ther. 2010 Feb;40(2):42-51. doi: 10.2519/jospt.2010.3337.
- Mo L, Jiang B, Mei T, Zhou D. Exercise Therapy for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis. Orthop J Sports Med. 2023 Jun 5;11(5):23259671231172773. doi: 10.1177/23259671231172773. eCollection 2023 May.
- Thomas DT, R S, Prabhakar AJ, Dineshbhai PV, Eapen C. Hip abductor strengthening in patients diagnosed with knee osteoarthritis - a systematic review and meta-analysis. BMC Musculoskelet Disord. 2022 Jun 29;23(1):622. doi: 10.1186/s12891-022-05557-6.
- Li E, Tan J, Xu K, Pan Y, Xu P. Global burden and socioeconomic impact of knee osteoarthritis: a comprehensive analysis. Front Med (Lausanne). 2024 May 16;11:1323091. doi: 10.3389/fmed.2024.1323091. eCollection 2024.
- Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, Callahan L, Copenhaver C, Dodge C, Felson D, Gellar K, Harvey WF, Hawker G, Herzig E, Kwoh CK, Nelson AE, Samuels J, Scanzello C, White D, Wise B, Altman RD, DiRenzo D, Fontanarosa J, Giradi G, Ishimori M, Misra D, Shah AA, Shmagel AK, Thoma LM, Turgunbaev M, Turner AS, Reston J. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020 Feb;72(2):149-162. doi: 10.1002/acr.24131. Epub 2020 Jan 6.
- Lee CL, Huang MH, Chai CY, Chen CH, Su JY, Tien YC. The validity of in vivo ultrasonographic grading of osteoarthritic femoral condylar cartilage: a comparison with in vitro ultrasonographic and histologic gradings. Osteoarthritis Cartilage. 2008 Mar;16(3):352-8. doi: 10.1016/j.joca.2007.07.013. Epub 2007 Oct 24.
- Karalilova R, Kazakova M, Batalov A, Sarafian V. Correlation between protein YKL-40 and ultrasonographic findings in active knee osteoarthritis. Med Ultrason. 2018 Feb 4;1(1):57-63. doi: 10.11152/mu-1247.
- Manske RC, Wolfe C, Page P, Voight M. Diagnostic Musculoskeletal Ultrasound in the Evaluation of Adductor Longus Injuries: Implications for Rehabilitation Providers. Int J Sports Phys Ther. 2025 Nov 1;20(11):1670-1674. doi: 10.26603/001c.146209. eCollection 2025.
- KELLGREN JH, LAWRENCE JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957 Dec;16(4):494-502. doi: 10.1136/ard.16.4.494. No abstract available.
- Bennell KL, Hunt MA, Wrigley TV, Hunter DJ, McManus FJ, Hodges PW, Li L, Hinman RS. Hip strengthening reduces symptoms but not knee load in people with medial knee osteoarthritis and varus malalignment: a randomised controlled trial. Osteoarthritis Cartilage. 2010 May;18(5):621-8. doi: 10.1016/j.joca.2010.01.010. Epub 2010 Feb 6.
- Bennell KL, Wrigley TV, Hunt MA, Lim BW, Hinman RS. Update on the role of muscle in the genesis and management of knee osteoarthritis. Rheum Dis Clin North Am. 2013 Feb;39(1):145-76. doi: 10.1016/j.rdc.2012.11.003. Epub 2012 Nov 22.
- Kean CO, Bennell KL, Wrigley TV, Hinman RS. Relationship between hip abductor strength and external hip and knee adduction moments in medial knee osteoarthritis. Clin Biomech (Bristol). 2015 Mar;30(3):226-30. doi: 10.1016/j.clinbiomech.2015.01.008. Epub 2015 Feb 3.
- Yuenyongviwat V, Duangmanee S, Iamthanaporn K, Tuntarattanapong P, Hongnaparak T. Effect of hip abductor strengthening exercises in knee osteoarthritis: a randomized controlled trial. BMC Musculoskelet Disord. 2020 May 7;21(1):284. doi: 10.1186/s12891-020-03316-z.
- Segal NA, Nevitt MC, Gross KD, Hietpas J, Glass NA, Lewis CE, Torner JC. The Multicenter Osteoarthritis Study: opportunities for rehabilitation research. PM R. 2013 Aug;5(8):647-54. doi: 10.1016/j.pmrj.2013.04.014.
- Deasy M, Leahy E, Semciw AI. Hip Strength Deficits in People With Symptomatic Knee Osteoarthritis: A Systematic Review With Meta-analysis. J Orthop Sports Phys Ther. 2016 Aug;46(8):629-39. doi: 10.2519/jospt.2016.6618. Epub 2016 Jul 3.
- Eijking HM, Verlaan L, Emans P, Boymans T, Meijer K, Senden R. Patient with knee osteoarthritis demonstrates improved knee adduction moment after knee joint distraction: a case report. Acta Orthop Belg. 2024 Mar;90(1):147-153. doi: 10.52628/90.1.11515.
- Lewis CL, Segal NA, Rabasa GV, LaValley MP, Williams GN, Nevitt MC, Lewis CE, Felson DT, Stefanik JJ. Hip Abductor Weakness and Its Association With New or Worsened Knee Pain: Data From the Multicenter Osteoarthritis Study. Arthritis Care Res (Hoboken). 2023 Nov;75(11):2328-2335. doi: 10.1002/acr.25160. Epub 2023 Jun 22.
- Bozan A, Erhan B. The relationship between quadriceps femoris thickness measured by US and femoral cartilage thickness in knee osteoarthritis, its effect on radiographic stage and clinical parameters: comparison with healthy young population. J Frailty Sarcopenia Falls. 2023 Sep 1;8(3):155-162. doi: 10.22540/JFSF-08-155. eCollection 2023 Sep.
- Tuna S, Balci N, Ozcakar L. The relationship between femoral cartilage thickness and muscle strength in knee osteoarthritis. Clin Rheumatol. 2016 Aug;35(8):2073-2077. doi: 10.1007/s10067-016-3271-4. Epub 2016 Apr 18.
- Moseng T, Vliet Vlieland TPM, Battista S, Beckwee D, Boyadzhieva V, Conaghan PG, Costa D, Doherty M, Finney AG, Georgiev T, Gobbo M, Kennedy N, Kjeken I, Kroon FPB, Lohmander LS, Lund H, Mallen CD, Pavelka K, Pitsillidou IA, Rayman MP, Tveter AT, Vriezekolk JE, Wiek D, Zanoli G, Osteras N. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update. Ann Rheum Dis. 2024 May 15;83(6):730-740. doi: 10.1136/ard-2023-225041.
- Hwang HS, Kim HA. Chondrocyte Apoptosis in the Pathogenesis of Osteoarthritis. Int J Mol Sci. 2015 Oct 30;16(11):26035-54. doi: 10.3390/ijms161125943.
- Sanchez-Lopez E, Coras R, Torres A, Lane NE, Guma M. Synovial inflammation in osteoarthritis progression. Nat Rev Rheumatol. 2022 May;18(5):258-275. doi: 10.1038/s41584-022-00749-9. Epub 2022 Feb 14.
- Cay HF, Akinci A, Altan L, Ataman S, Aydogdu S, Diracoglu D, Genc H, Hepguler S, Ketenci A, Ones K, Uyar M, Gumru S, Hacibedel B, Helvacioglu K, Olmez A, Tuncer T. Evaluation of disease burden, patient journey, unmet diagnosis and treatment needs of patients with HIP and knee osteoarthritis in Turkey: A study through Delphi Methodology. Osteoarthr Cartil Open. 2022 Dec 24;5(1):100332. doi: 10.1016/j.ocarto.2022.100332. eCollection 2023 Mar.
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Arvioitu)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muut tutkimustunnusnumerot
- PamukkaleU.ftr-MArbayCeltek-01
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Polven nivelrikko
-
Mackay Memorial HospitalIlmoittautuminen kutsustaYhteisö | Intentionality the Matrix of Healing | Keski-ikäiset ja vanhemmat aikuiset | Suun terveyden opetusTaiwan
-
Maastricht University Medical CenterWingate Institute of NeurogastroenterologyRekrytointifMRI | Transkutaaninen vagal-hermostimulaatio (tVNS) | Nucleus of the Solitary Tract (NTS)Alankomaat, Yhdistynyt kuningaskunta
-
Tokat Gaziosmanpasa UniversityIlmoittautuminen kutsustaThe Effects of Video Game Playing Habits and Some Sports Activities on Intubation Performance With Video LaryngoscopyTurkki
-
Johannes Gutenberg University MainzDentsply Sirona ImplantsTuntematonDistaalisen alaleuan kalteva atrofia | Socket Like Atrophy of the Aesthetic ZoneSaksa
-
The University of Tennessee, KnoxvilleMicroPort Orthopedics Inc.PeruutettuPolven nivelrikko | Polven vammat | Täydellinen polven artroplastia | Knee ImlantYhdysvallat
-
Poitiers University HospitalValmisÄidin tai sikiön tartunnan tunnistaminen SARS Cov-2:lla | Tutki virusten esiintymistä äidin ja sikiön tai isän eri paikoissa | Kysely perustuu Poitou-Charentesin CPDPN:n ympärille jo järjestettyyn verkkotyöhön | Analysis Laboratories of the Poitiers CHURanska
Kliiniset tutkimukset Quadriceps Plus Hip Strengthening Exercises
-
Ottawa Hospital Research InstituteCorinValmis
-
Tongji HospitalThe Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... ja muut yhteistyökumppanitRekrytointiHepatosellulaarinen karsinooma Ei leikattavissaKiina
-
Organon and CoValmis